| Literature DB >> 17942559 |
Sonia Molina1, Valerie Castet, Lydiane Pichard-Garcia, Czeslaw Wychowski, Eliane Meurs, Jean-Marc Pascussi, Camille Sureau, Jean-Michel Fabre, Antonio Sacunha, Dominique Larrey, Jean Dubuisson, Joliette Coste, Jane McKeating, Patrick Maurel, Chantal Fournier-Wirth.
Abstract
Hepatitis C virus-positive serum (HCVser, genotypes 1a to 3a) or HCV cell culture (JFH1/HCVcc) infection of primary normal human hepatocytes was assessed by measuring intracellular HCV RNA strands. Anti-CD81 antibodies and siRNA-CD81 silencing markedly inhibited (>90%) HCVser infection irrespective of HCV genotype, viral load, or liver donor, while hCD81-large intracellular loop (LEL) had no effect. However, JFH1/HCVcc infection of hepatocytes was modestly inhibited (40 to 60%) by both hCD81-LEL and anti-CD81 antibodies. In conclusion, CD81 is involved in HCVser infection of human hepatocytes, and comparative studies of HCVser versus JFH1/HCVcc infection of human hepatocytes and Huh-7.5 cells revealed that the cell-virion combination is determinant of the entry process.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17942559 PMCID: PMC2224376 DOI: 10.1128/JVI.01443-07
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103